Phase II Study of GTx024 in Women With Metastatic Breast Cancer
NCT01616758
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
GTx-024 9mg
Sponsor
GTx